TP53 and neoplasm: Interestingly, wild-type p53 reintroduction into engineered p53-deficient mice, reminiscent of pharmacological reactivation of mutant p53, can induce senescence and trigger antitumor immunity,10,11 defining the unconventional non-cell-autonomous tumor suppression function of p53.41